Fatty liver mediated by peroxisome proliferator-activated receptor-α DNA methylation can be reversed by a methylation inhibitor and curcumin-Reference-Cited by-同舟云学术

Fatty liver mediated by peroxisome proliferator-activated receptor-α DNA methylation can be reversed by a methylation inhibitor and curcumin

Published:2018-07 Issue:7 Volume:19 Page:421-430
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Li Yu Yuan¹,Tang Dan¹,Du Yan Lei¹,Cao Chuang Yu¹,Nie Yu Qiang¹,Cao Jie¹,Zhou Yong Jian¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Guangzhou Digestive Diseases Center, Guangzhou First People's Hospital; Guangzhou Medical University; Guangzhou, Guangdong Province China

Publisher

Wiley

Subject

Gastroenterology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1751-2980.12610/fullpdf

Reference38 articles.

1. Nonalcoholic fatty liver disease - current status and future directions;Demir;J Dig Dis,2015

2. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

3. Prevalence of fatty liver disease and its risk factors in the population of South China;Zhou;World J Gastroenterol,2007

4. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection;Starley;Hepatology,2010

5. Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study;Zhou;J Dig Dis,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review;Antioxidants;2024-06-29

2. Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis;Frontiers in Pharmacology;2024-01-19

3. Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD);Frontiers in Molecular Medicine;2024-01-08

4. The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction;Cells;2023-08-18

5. Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease;Molecules;2023-07-25